Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Müller-Spahn

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Fortschritte Der Neurologie-Psychiatrie|September 1, 1991
[Clinical effectiveness of zotepine in treatment of negative schizophrenic symptoms. Results of an open and a double-blind controlled trial]F Müller-Spahn, D Dieterle, M Ackenheil
International Clinical Psychopharmacology|May 1, 1996
The psychobiology of the acute schizophrenic episodeF Müller-Spahn, P Eich, C Hock
Annals of the New York Academy of Sciences|January 17, 1996
Computer-based cognitive training in Alzheimer's disease patientsM Hofmann, C Hock, F Müller-Spahn
Der Nervenarzt|July 1, 1992
[New aspects in the diagnosis, pathogenesis and therapy of schizophrenic negative symptoms]F Müller-Spahn, S Modell, M Thomma
Der Nervenarzt|May 1, 1993
[Paranoid psychosis in a patient with hypothyroidism and vitamin B12 deficiency]S Modell, D Naber, F Müller-Spahn
Fortschritte Der Neurologie-Psychiatrie|November 1, 1993
[Atypical neuroleptics, pharmacology and clinical importance]U Klages, H Hippius, F Müller-Spahn
Versicherungsmedizin|June 1, 1994
[Prognosis of depression in the elderly]U Klages, C Hock, F Müller-Spahn
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Psychodrug-induced and EDTA associated thrombocytopenia: important factors in the differential diagnosis of low platelet countsH Hampel, C Berger, F Müller-Spahn
Acta Haematologica|January 1, 1996
Modified oral anticoagulant potency in an amitriptyline-treated patient?H Hampel, C Berger, F Müller-Spahn
Pharmacopsychiatry|February 24, 2010
Mania associated with mirtazepine treatment and mixed depressionB Habermeyer, U Bayer, F Müller-Spahn
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Fortschritte Der Neurologie-Psychiatrie|September 1, 1991
[Clinical effectiveness of zotepine in treatment of negative schizophrenic symptoms. Results of an open and a double-blind controlled trial]F Müller-Spahn, D Dieterle, M Ackenheil
International Clinical Psychopharmacology|May 1, 1996
The psychobiology of the acute schizophrenic episodeF Müller-Spahn, P Eich, C Hock
Annals of the New York Academy of Sciences|January 17, 1996
Computer-based cognitive training in Alzheimer's disease patientsM Hofmann, C Hock, F Müller-Spahn
Der Nervenarzt|July 1, 1992
[New aspects in the diagnosis, pathogenesis and therapy of schizophrenic negative symptoms]F Müller-Spahn, S Modell, M Thomma
Der Nervenarzt|May 1, 1993
[Paranoid psychosis in a patient with hypothyroidism and vitamin B12 deficiency]S Modell, D Naber, F Müller-Spahn
Fortschritte Der Neurologie-Psychiatrie|November 1, 1993
[Atypical neuroleptics, pharmacology and clinical importance]U Klages, H Hippius, F Müller-Spahn
Versicherungsmedizin|June 1, 1994
[Prognosis of depression in the elderly]U Klages, C Hock, F Müller-Spahn
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Psychodrug-induced and EDTA associated thrombocytopenia: important factors in the differential diagnosis of low platelet countsH Hampel, C Berger, F Müller-Spahn
Acta Haematologica|January 1, 1996
Modified oral anticoagulant potency in an amitriptyline-treated patient?H Hampel, C Berger, F Müller-Spahn
Pharmacopsychiatry|February 24, 2010
Mania associated with mirtazepine treatment and mixed depressionB Habermeyer, U Bayer, F Müller-Spahn
Pageof 10